Correlation Between Zillow Group and Zenas BioPharma,

Can any of the company-specific risk be diversified away by investing in both Zillow Group and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zillow Group and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zillow Group Class and Zenas BioPharma, Common, you can compare the effects of market volatilities on Zillow Group and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zillow Group with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zillow Group and Zenas BioPharma,.

Diversification Opportunities for Zillow Group and Zenas BioPharma,

-0.82

Correlation Coefficient

Zillow Group  Zenas BioPharma,

Pay attention - limited upside

The 3 months correlation between Zillow and Zenas is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Zillow Group Class and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Zillow Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zillow Group Class are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Zillow Group i.e., Zillow Group and Zenas BioPharma, go up and down completely randomly.

Pair Corralation between Zillow Group and Zenas BioPharma,

Taking into account the 90-day investment horizon Zillow Group Class is expected to under-perform the Zenas BioPharma,. But the etf apears to be less risky and, when comparing its historical volatility, Zillow Group Class is 2.91 times less risky than Zenas BioPharma,. The etf trades about -0.15 of its potential returns per unit of risk. The Zenas BioPharma, Common is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  1,044  in Zenas BioPharma, Common on September 22, 2024 and sell it today you would lose (68.00) from holding Zenas BioPharma, Common or give up 6.51% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Zillow Group Class  vs.  Zenas BioPharma, Common

Zillow Group Class

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Zillow Group Class are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Zillow Group showed solid returns over the last few months and may actually be approaching a breakup point.

Zenas BioPharma, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zenas BioPharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Etf's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the ETF investors.

Pair Trading with Zillow Group and Zenas BioPharma,

The main advantage of trading using opposite Zillow Group and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zillow Group position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.

The idea behind Zillow Group Class and Zenas BioPharma, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.